Rheumatoid Arthritis

Australia's national science agency CSIRO has identified a new gene that plays a critical role in regulating the body's immune response to infection and disease. The discovery could lead to the development of new treatments for influenza, arthritis and even cancer. The gene, called C6orf106 or "C6", more

Peptides are short chains of amino acids that can bind to proteins and change their function. They show high binding affinity, low toxicity, and are easy to synthesize, all of which makes peptides ideal for use in drug development, and many naturally occurring peptides such as insulin, oxytocin, som more

A treatment that improves the lives of nearly 1.3 million people with rheumatoid arthritis might one day originate from scorpion venom. A group of researchers led by Dr. Christine Beeton at Baylor College of Medicine has found that one of the hundreds of components in scorpion venom can reduce the s more

Publication date: 30 August 2018 Source:European Journal of Pharmaceutical Sciences, Volume 121 Author(s): Annalisa Dalmoro, Sabrina Bochicchio, Shamil F. Nasibullin, Paolo Bertoncin, Gaetano Lamberti, Anna Angela Barba, Rouslan I. Moustafine Non-steroidal anti-inflammatory drugs more

Methotrexate (MTX) monotherapy is a common first treatment for rheumatoid arthritis (RA), but many patients do not respond adequately. In order to identify genetic predictors of response, we have combined data from two consortia to carry out a genome-wide study of response to MTX in 1424 early RA pa more

Neurobiological similarities between RA and fibromyalgia Neurobiological similarities between RA and fibromyalgia, Published online: 15 May 2018; doi:10.1038/s41584-018-0011-y Pain management can be a difficult problem for patients with rheumatoid arthritis (RA), some of whom can experience pain s more

TechNavio’s analysts forecast the Rheumatoid Arthritis market in Japan to grow at a CAGR of 29.2 percent over the period 2011–2015. One of the key factors contributing to this market growth is the high prevalence rate of patients suffering from rheumatoid arthritis. The Rheumatoid Arthritis Drugs ma more

BMI View: Estonia’s pharmaceutical market will remain of marginal interest to multinationals given its small population and a modest growth outlook. We expect the market to post a five-year compound annual growth rate (CAGR) of 5.07% in local currency terms through to 2016, with the following five y more

Introduction GlobalData's analysis alert "The Rheumatoid Arthritis Community is Swelling with Anticipation as its Research Pipeline Begins to Burst”, analyzes the current pipeline for rheumatoid arthritis drug therapeutics. In addition to the anticipated upcoming approval of Pfizer’s tofacitinib, more